|
Market Cap (4-Jun) $16,057,089 (1,586th) |
Close (30-Jun) $0.375 |
Volume (30-Jun) 3,448 |
Shortsold (16-Aug) 1,155 (0.00%) (595th) |
|
52w High $0.79 |
52w Low $0.110 |
P/E - |
EPS -0.08 |
AGN released this announcement to the ASX on 4 April 2022, 8:16. The announcement is marked as price sensitive, and is 2 page(s) in length and 230.49kb in size.
You can view all announcements from AGN and see how they appear on a price chart on the announcements page.
At the date of this announcement, AGN was 0.000% short sold according to ASIC data. It was ranked the 653rd most shorted stock on the ASX. It is now ranked as the 595th most shorted stock on the ASX with 0.001% of total shares short sold as of the latest reported data (16 August 2024).
| Other Recent Announcements from AGN | |
|---|---|
| ARG-007 Protects Brain Cells in Moderate TBI Model | 22 June 2023, 8:19 |
| Becoming a substantial holder | 20 June 2023, 8:21 |
| Becoming a substantial holder | 13 June 2023, 17:34 |
| Argenica Appoints CEO Dr Liz Dallimore Managing Director | 4 April 2022, 8:16 |
| Positive Preclincal Data on Efficacy in New Indication | 30 March 2022, 8:26 |
| Peer Reviewed Paper Published on Preclinical Study | 21 March 2022, 8:23 |
| Investor Presentation | 16 March 2022, 8:24 |
You must be logged in to post a reply.
